Today's Date
Immunotherapy to Preserve Residual Insulin in New-onset Type One Diabetes
(
IMPRINT
)
ITN Protocol #:
ITN078AI
Branded Name:
IMPRINT
Treatment Protocol #:
Therapeutic Area:
Type 1 Diabetes
Current Status:
Withdrawn
Summary:
Immunotherapy to Preserve Residual Insulin in New-onset Type One Diabetes
Clinical Operations Associate Director & Manager
ITN Clinical Trial Physician
NIAID Project Manager
Study Personnel:
